|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.350 USD | +0.86% |
|
-3.69% | +44.17% |
| 08/07 | Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer | MT |
| 08/07 | Ovid Therapeutics Inc. Announces Executive Changes, Effective July 6, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 2.76 | 2.96 | 2.91 |
| Spread/Res. | -14.86% | -20.61% | -19.24% |
| Spread/Supp. | +6.33% | +16.92% | +27.72% |
| Support | 2.21 | 2.01 | 1.84 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- OVID Stock
- Charts Ovid Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
